Clinical Trial Design — The R&D Dilemma
Sponsored by:
Insightful Speakers:
Kenneth Kaitin, PhD, Director of the Tufts Center for the Study of Drug Development and Michael O’Connell, Director of Life Sciences; Insightful Corporation Hosted by:
John Carroll, Editor FierceBiotech From competition for volunteers to the emphasis on safety forcing developers to rethink how they assess drug data, clinical trials are growing longer, costlier and more complex. Join FierceBiotech and Tufts' development expert as we discuss new trends in clinical trial design that can give developers a key advantage in controlling cost and maximizing efficiency. Register today!
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
